TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 7,650.00
+500.00 (6.99%)
At close: Mar 13, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 222.45 billion as of March 13, 2026. Its market cap has increased by 138.96% in one year.
Market Cap
222.45B
Enterprise Value
225.44B
Revenue
9.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,650.00
Market Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 222.45B, a decrease of -28.68%. That is a compound annual growth rate of -5.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 207.91B | 21.88% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 345.12B |
| NIBEC | 335.29B |
| Bio Solution | 281.85B |
| ABION | 243.27B |
| Genome & Company | 243.20B |
| Kangstem Biotech | 212.56B |
| Prestige Biologics | 202.16B |
| ISU Abxis | 201.57B |